Table 2. Distribution of study variables and their association with availability of NCD medicines.
| Variable | N (%) | Essential medicines availability, n (%) | p* | ||
|---|---|---|---|---|---|
| None present | 1–3 present | 4 or more present | |||
| Region | 0.04 | ||||
| West | 23 (11.7) | 12 (52.2) | 5 (21.7) | 6 (26.1) | |
| North | 63 (32.1) | 17 (27.0) | 29 (46.0) | 17 (27.0) | |
| East | 64 (32.7) | 32 (50.0) | 21 (32.8) | 11 (17.2) | |
| South | 46 (23.5) | 12 (26.1) | 21 (45.7) | 13 (28.3) | |
| Facility type | <0.01 | ||||
| General hospital | 17 (8.7) | 0 (0) | 1 (5.9) | 16 (94.1) | |
| HC-IV | 17 (8.7) | 2 (11.8) | 4 (25.5) | 11 (64.7) | |
| HC-III | 68 (34.7) | 6 (8.8) | 50 (73.5) | 12 (17.7) | |
| HC-II | 94 (48.0) | 65 (69.2) | 21 (22.3) | 8 (8.5) | |
| Managing authority | <0.01 | ||||
| Public | 125 (63.8) | 60 (48.0) | 47 (37.6) | 18 (14.4) | |
| Private non-profit | 43 (21.9) | 6 (14.0) | 16 (37.2) | 21 (48.8) | |
| Private for-profit | 28 (14.3) | 7 (25.0) | 13 (46.4) | 8 (28.6) | |
| HCT^ available | 152 (77.6) | 41 (27.0) | 65 (42.8) | 46 (30.3) | <0.01 |
| HIV care services available | 113 (57.7) | 30 (26.6) | 48 (42.5) | 35 (31.0) | |
Note: Percentages may not sum to 100% due to rounding. Frequencies and percentages reflect unweighted data.
* P-value for χ2 test.
^HCT = HIV Counseling and Testing